Choice Help: Optimizing Outcomes by Supporting Encounters for Kids with Congenital Melanocytic Nevi
We need tools to support shared decision-making in pediatric dermatology as well as studies evaluating this process. Choice Help: Optimizing Outcomes by Supporting Encounters for kids with Congenital Melanocytic Nevi (CHOOSE CMN) aims to (1) elicit patient/family values informing medical decision-making for patients with congenital nevi, and (2) test the feasibility of a patient decision aid concerning neural melanosis screening and surgical interventions.
— Carrie C. Coughlin, M.D.
- Washington University School of Medicine
- Pediatric Dermatology Career Development Award
Categories: Featured Researchers
Tags: 2021 Research Awards, Nevi and Melanoma, Pediatric Dermatology and Children
Related Articles
Exploring Gene Expression Patterns and Biomarkers of Disease Severity in Central Centrifugal Cicatricial Alopecia
Central centrifugal cicatricial alopecia (CCCA), which has been associated with uterine fibroids, is unlike other scarring alopecias because fibrosis rather…
Characterizing the Microbiome in Postmenopausal Women with Vulvar Lichen Sclerosus
Vulvar lichen sclerosus is a chronic inflammatory condition that leads to scarring, obliteration of normal vulvar architecture, dyspareunia, and significant…
Cell Signaling Changes Induced by Surgical Debulking May Improve Response to Smoothened Inhibitor Therapy
Smoothened (SMO) inhibitors, such as vismodegib, are effective treatments for locally advanced basal cell carcinomas (BCCs). However, recurrences are frequent…